AERTS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AERTS PHARMA
Largest movements
- Cash +€134,178
up €134,178 (+105.2%), from €127,589 to €261,767
mainly Net result for the year (+€178,015) and Trade debts (+€154,770)
- Tangible fixed assets -€55,657
down €55,657 (-12.9%), from €430,528 to €374,870
- Receivables within one year +€11,404
up €11,404 (+9.7%), from €117,831 to €129,235
of which Other amounts receivable: +€11,009
- Trade debts +€154,770
up €154,770 (+223.1%), from €69,387 to €224,156
- Debts after one year -€35,324
down €35,324 (-24.0%), from €147,059 to €111,735
- Other debts -€32,694
down €32,694 (-5.2%), from €625,881 to €593,187
- Gross operating margin -€43,287
down €43,287 (-10.5%), from €411,395 to €368,107
- Taxes -€10,455
down €10,455 (-35.9%), from €29,121 to €18,666
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €956,830 | €1,042,560 | +€85,730 | +9.0% |
| Fixed assets | 21/28 | €430,528 | €374,870 | -€55,657 | -12.9% |
| Tangible fixed assets | 22/27 | €430,528 | €374,870 | -€55,657 | -12.9% |
| Land and buildings | 22 | €353,873 | €334,312 | -€19,561 | -5.5% |
| Plant, machinery and equipment | 23 | €23,254 | €12,015 | -€11,239 | -48.3% |
| Furniture and vehicles | 24 | €53,401 | €28,543 | -€24,858 | -46.5% |
| Current assets | 29/58 | €526,302 | €667,689 | +€141,387 | +26.9% |
| Stocks and contracts in progress | 3 | €272,660 | €266,788 | -€5,872 | -2.2% |
| Stocks | 30/36 | €272,660 | €266,788 | -€5,872 | -2.2% |
| Amounts receivable within one year | 40/41 | €117,831 | €129,235 | +€11,404 | +9.7% |
| Trade receivables | 40 | €117,446 | €117,841 | +€395 | +0.3% |
| Other amounts receivable | 41 | €384 | €11,394 | +€11,009 | +2864.2% |
| Cash at bank and in hand | 54/58 | €127,589 | €261,767 | +€134,178 | +105.2% |
| Deferred charges and accrued income | 490/1 | €8,222 | €9,899 | +€1,677 | +20.4% |
| Total equity and liabilities | 10/49 | €956,830 | €1,042,560 | +€85,730 | +9.0% |
| Equity | 10/15 | €53,868 | €53,884 | +€15 | 0.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €41,468 | €41,484 | +€15 | 0.0% |
| Distributable reserves | 133 | €41,468 | €41,484 | +€15 | 0.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €902,961 | €988,676 | +€85,715 | +9.5% |
| Amounts payable after more than one year | 17 | €147,059 | €111,735 | -€35,324 | -24.0% |
| Financial debts | 170/4 | €147,059 | €111,735 | -€35,324 | -24.0% |
| Amounts payable within one year | 42/48 | €751,250 | €873,038 | +€121,788 | +16.2% |
| Current portion of amounts payable after more than one year | 42 | €33,802 | €35,324 | +€1,522 | +4.5% |
| Trade debts | 44 | €69,387 | €224,156 | +€154,770 | +223.1% |
| Suppliers | 440/4 | €69,387 | €224,156 | +€154,770 | +223.1% |
| Advances received on contracts in progress | 46 | €1,437 | €2,094 | +€657 | +45.8% |
| Taxes, remuneration and social security | 45 | €20,744 | €18,277 | -€2,467 | -11.9% |
| Taxes | 450/3 | €2,378 | €1,892 | -€486 | -20.4% |
| Remuneration and social security | 454/9 | €18,366 | €16,385 | -€1,981 | -10.8% |
| Other amounts payable | 47/48 | €625,881 | €593,187 | -€32,694 | -5.2% |
| Accrued charges and deferred income | 492/3 | €4,652 | €3,903 | -€749 | -16.1% |
| Remuneration, social security and pensions | 62 | €103,064 | €100,529 | -€2,535 | -2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55,657 | €55,657 | = | 0.0% |
| Other operating charges | 640/8 | €3,655 | €3,851 | +€197 | +5.4% |
| Gross operating margin | 9900 | €411,395 | €368,107 | -€43,287 | -10.5% |
| Operating profit (loss) | 9901 | €249,019 | €208,070 | -€40,949 | -16.4% |
| Financial income | 75/76B | €1,295 | €710 | -€584 | -45.1% |
| Recurring financial income | 75 | €1,295 | €710 | -€584 | -45.1% |
| Financial charges | 65/66B | €13,145 | €12,099 | -€1,046 | -8.0% |
| Recurring financial charges | 65 | €13,145 | €12,099 | -€1,046 | -8.0% |
| Profit (loss) for the period before taxes | 9903 | €237,169 | €196,681 | -€40,487 | -17.1% |
| Income taxes | 67/77 | €29,121 | €18,666 | -€10,455 | -35.9% |
| Profit (loss) for the period | 9904 | €208,048 | €178,015 | -€30,032 | -14.4% |
| Profit (loss) for the period to be appropriated | 9905 | €208,048 | €178,015 | -€30,032 | -14.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.